Sims Karen's most recent trade in Arbutus Biopharma Corp was a trade of 200,300 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 14, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Arbutus Biopharma Corp | Karen Sims | Chief Medical Officer | 14 Feb 2025 | 200,300 | 200,300 | - | - | Stock Option (Right to Buy) | ||
| Arbutus Biopharma Corp | Karen Sims | Chief Medical Officer | 14 Feb 2025 | 49,300 | 155,494 (0%) | 0% | 0 | Common Shares | ||
| Arbutus Biopharma Corp | Karen Sims | Chief Medical Officer | 04 Feb 2025 | 19,348 | 106,194 (0%) | 0% | 3.3 | 63,519 | Common Shares | |
| Arbutus Biopharma Corp | Karen Sims | Chief Medical Officer | 01 Feb 2024 | 403,900 | 403,900 | - | - | Stock Option (Right to Buy) | ||
| Arbutus Biopharma Corp | Karen Sims | Chief Medical Officer | 01 Feb 2024 | 101,000 | 129,900 (0%) | 0% | 0 | Common Shares | ||
| Arbutus Biopharma Corp | Sims Karen | Chief Medical Officer | 01 Feb 2024 | 4,358 | 125,542 (0%) | 0% | 2.3 | 10,078 | Common Shares | |
| Arbutus Biopharma Corp | Karen Sims | Chief Medical Officer | 10 Jul 2023 | 153,640 | 153,640 | - | - | Stock Option (Right to Buy) |